| Literature DB >> 36034184 |
Min Xiao1, Di Wang2, Guo-Ling Lin1, Xin Lin3, Li-Yan Tao4, Qi-Yong Li1,5.
Abstract
Purpose: To explore the feasibility and safety of using the left lateral decubitus position (LLDP) to perform laparoscopic liver resection (LLR) for the treatment of hepatic lesions in segment VI and/or VII. Patients andEntities:
Keywords: laparoscopic; left lateral decubitus position; liver resection
Year: 2022 PMID: 36034184 PMCID: PMC9401608 DOI: 10.2147/IJGM.S376919
Source DB: PubMed Journal: Int J Gen Med ISSN: 1178-7074
Figure 1Using the LLDP to perform LLR. (A) Five trocars were placed into the abdominal cavity in the lateral position to allow for the completion of the LLR. The five holes were located at the junctions 3 cm below the right costal arch (F) and the right anterior axillary line (D), midline (E), axillary midline (C), posterior axillary line (B), and subscapular line (A). (B) After general anesthesia and endotracheal intubation were administered, the patient was placed in the LLDP and a towel was positioned following routine disinfection. (C) Each layer was gradually cut into using an electric knife in the trocar D position. (D) LLR in the LLDP was performed after the trocars were replaced.
Patient Demographics and Surgical Outcomes
| Characteristic | LLDP | ROP | |
|---|---|---|---|
| Cases | 25 | 25 | |
| Sex | 0.771 | ||
| Male | 15 (60.0%) | 16 (64.0%) | |
| Female | 10 (40.0%) | 9 (36.0%) | |
| Age (years) | 52.8 ± 11.9 | 54.4±10.6 | 0.608 |
| Body mass index (kg/m2) | 24.1 ± 3.2 | 23.8±3.8 | 0.774 |
| Before surgery | |||
| Hepatitis viral infection | 15 (60.0%) | 13 (52.0%) | 0.569 |
| PT (s) | 12.2 ± 0.8 | 12.2±1.3 | 0.970 |
| INR | 1.06 ± 0.08 | 1.05 ± 0.11 | 0.720 |
| TB (μmol/L) | 15.3 ± 6.6 | 14.6 ± 5.5 | 0.676 |
| Child-Pugh | |||
| A | 25 (100.0%) | 25 (100.0%) | |
| B and C | 0 (0.0%) | 0 (0.0%) | |
| Lesion location (Couinaud) | 0.03 | ||
| Segment VI | 7 (28.0%) | 19 (76.0%) | |
| Segment VII | 12 (48.0%) | 3 (12.0%) | |
| Segments VI and VII | 6 (24.0%) | 3 (12.0%) | |
| During surgery | |||
| Conversion to open | 0 (0.0%) | 2 (8.0%) | 0.470 |
| Operative time (min) | 256.9 ± 132.7 | 255.7 ± 92.1 | 0.971 |
| Blood loss (mL) | 100 (50–250) | 200 (50–425) | 0.122 |
| Blood transfusion during surgery | 1 (4.0%) | 5 (20.0%) | 0.192 |
| After surgery | |||
| Size of lesion (mm) | 22.3 (11.5–56.6) | 33.0 (16.0–52.0) | 0.180 |
| Pathology | 0.991 | ||
| HCC | 15 | 16 | |
| Hemangioma | 8 | 5 | |
| FNH | 1 | 1 | |
| Metastatic pancreatic cancer | 1 | 1 | |
| Cholangiocarcinoma | 0 | 1 | |
| PEComa | 0 | 1 | |
| Morbidity | |||
| Pleural effusion | 4 (16.0%) | 6 (24.0%) | 0.724 |
| Electrolyte disturbances | 3 (12.0%) | 5 (20.0%) | 0.700 |
| Gastrointestinal reaction | 4 (16.0%) | 0 (0.0%) | 0.110 |
| High fever | 2 (8.0%) | 1 (4.0%) | 1.000 |
| Abdominal infection | 1 (4.0%) | 0 (0.0%) | 1.000 |
| Days to remove the drainage tube (days) | 7.8 (± 4.1) | 10.4 (± 3.9) | 0.027 |
| Days after surgery (days) | 15.6 (± 5.2) | 19.3 (±5.9) | 0.025 |
Abbreviations: PT, prothrombin time; INR, International Normalized Ratio; TB, total bilirubin; HCC, hepatocellular carcinoma; FNH, focal nodular hyperplasia; PEComa, perivascular epithelioid cell tumor.
Figure 2Postoperative examination indexes of the patients. The four examination indexes are expressed as the median in the graphs. (A) The ALT of the patients after the operation. (B) The AST of the patients after the operation. (C) The PT of the patients after the operation. (D) The TB of the patients after the operation. After the operation, the biochemical standards of the patients tended to gradually return to normal within five days both in the LLDP and ROP.